CKD Bio Corp. (063160.KS)
063160.KS Stock Price Chart
Explore CKD Bio Corp. interactive price chart. Choose custom timeframes to analyze 063160.KS price movements and trends.
063160.KS Company Profile
Discover essential business fundamentals and corporate details for CKD Bio Corp. (063160.KS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
4 Jan 2000
Employees
519.00
Website
https://www.ckdbio.comCEO
Hui Yil Kang
Description
CKD Bio Corp. manufactures and distributes drug substances based on fermentation, synthesis, and biotechnology in South Korea. It offers drug substances in the areas of antibiotic, ß-lactamase inhibitors, immunosuppressants, anticancer drugs, obesity treatment drugs, dry eye, antivirus, antituberculosis, antihyperlipidemics, and probiotics. The company also provides contract research and development, and manufacturing services for active pharmaceutical ingredients and intermediates, and probiotics. It also exports its products. The company was founded in 1941 and is headquartered in Seoul, South Korea.
063160.KS Financial Timeline
Browse a chronological timeline of CKD Bio Corp. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 23 Apr 2026
Upcoming earnings on 23 Jan 2026
Upcoming earnings on 23 Oct 2025
Earnings released on 25 Jul 2025
Earnings released on 15 May 2025
EPS came in at ₩164.06 , while revenue for the quarter reached ₩42.52B .
Earnings released on 18 Mar 2025
EPS came in at ₩215.04 , while revenue for the quarter reached ₩31.42B .
Dividend declared on 27 Dec 2024
A dividend of ₩100.00 per share was announced, adjusted to ₩100.00. The dividend was paid on 1 Apr 2025.
Earnings released on 25 Oct 2024
EPS came in at ₩51.95 , while revenue for the quarter reached ₩43.89B .
Earnings released on 26 Jul 2024
EPS came in at ₩802.79 , while revenue for the quarter reached ₩50.91B .
Earnings released on 26 Apr 2024
EPS came in at ₩516.19 , while revenue for the quarter reached ₩45.54B , beating expectations by +26.01K%.
Earnings released on 20 Mar 2024
EPS came in at -₩1.48K , while revenue for the quarter reached ₩35.33B .
Earnings released on 27 Oct 2023
EPS came in at -₩1.17K , while revenue for the quarter reached ₩42.34B .
Earnings released on 28 Jul 2023
EPS came in at -₩1.23K , while revenue for the quarter reached ₩38.98B .
Earnings released on 28 Apr 2023
EPS came in at -₩529.59 , while revenue for the quarter reached ₩43.70B .
Earnings released on 30 Jan 2023
EPS came in at -₩1.29K , while revenue for the quarter reached ₩34.91B , missing expectations by -10.93%.
Earnings released on 28 Oct 2022
EPS came in at -₩638.00 , while revenue for the quarter reached ₩37.59B , missing expectations by -16.46%.
Earnings released on 29 Jul 2022
EPS came in at -₩897.00 , while revenue for the quarter reached ₩36.67B , missing expectations by -18.14%.
Earnings released on 29 Apr 2022
EPS came in at -₩219.57 , while revenue for the quarter reached ₩46.86B .
Earnings released on 28 Jan 2022
EPS came in at -₩152.07 , while revenue for the quarter reached ₩33.27B .
Dividend declared on 29 Dec 2021
A dividend of ₩100.00 per share was announced, adjusted to ₩100.00. The dividend was paid on 11 Apr 2022.
Earnings released on 29 Oct 2021
EPS came in at -₩777.00 , while revenue for the quarter reached ₩37.96B .
Earnings released on 30 Jul 2021
EPS came in at ₩87.00 , while revenue for the quarter reached ₩37.48B .
Earnings released on 30 Apr 2021
EPS came in at -₩357.00 , while revenue for the quarter reached ₩33.53B .
Earnings released on 9 Feb 2021
EPS came in at -₩183.09 , while revenue for the quarter reached ₩26.79B .
Dividend declared on 29 Dec 2020
A dividend of ₩200.00 per share was announced, adjusted to ₩200.00. The dividend was paid on 9 Apr 2021.
Earnings released on 30 Oct 2020
EPS came in at ₩252.00 , while revenue for the quarter reached ₩32.68B .
063160.KS Stock Performance
Access detailed 063160.KS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.